IPN, New Delhi can facilitate patient to import of "Oncology Products" for personal use under "patient name basis" treatment in India. For this applicant is required to make an request application with required document. IPN, New Delhi will do the necessary process to obtain permission from Drugs Controller General (India) to import.
The following lists anti-cancer drugs, US FDA and Indian Generic brand approved by the Food and Drug Administration (FDA) for Other Diseases treatment. The list includes generic and brand names are in some way related to, or used in the treatment of this condition. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
For migraine Treatment
NURTEC ODT (rimegepant) orally disintegrating tablets, for sublingual or oral use Initial U.S. Approval: 2020
For glucocorticoid levels Treatment
FLORINEF ® (fludrocortisone acetate) 0.1 mg Tablets
For diarrhea Treatment
DIFICID (fidaxomicin) for oral suspension Initial U.S. Approval: 2011
For osteoporosis (Bone) Treatment
EVENITY ™ (romosozumab-aqqg) injection, for subcutaneous use Initial U.S. Approval: 2019
For cardiovascular Treatment
VERQUVO TM (vericiguat) tablets, for oral use Initial U.S. Approval: 2021
For Crohn's Disease Treatment
STELARA ® (Ustekinumab) Injection, For Subcutaneous Or Intravenous Use Initial U.S. Approval: 2009.
For Asthma Treatment
NUCALA (mepolizumab) injection, for subcutaneous use Initial U.S. Approval: 2015
For immune system Treatment
Firazyr (Icatibant) Injection, for subcutaneous use Initial U.S. Approval: 2011
For urinary tract infections Treatment
FETROJA (cefiderocol) for injection, for intravenous use Initial U.S. Approval: 2019
We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.
Indian Pharma Network is registered medical pharmacy for Oncology Products in India.Helps you to access FDA approved Other Diseases medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Other Diseases Medicines in China, UAE, Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
If you have a question relating to anti-cancer medicines approved for treatment of Other Diseases, a problem which you do not know how to resolve it, or concrete inquiry - we are here for you. We will answer you via email urgent@indianpharmanetwork.co.in as soon as possible. If you prefer to be contacted by phone, please leave your phone number. Or text your message in WhatsApp Number +91 9891296838 / 9811747774.
The list includes US FDA approved brand drugs names are in some way related to, or used in the treatment of this condition.
IPN, New Delhi can facilitate patient to import of "Oncology Products" for personal use under "patient name basis" treatment in India.
The list includes US FDA approved brand drugs names are in some way related to, or used in the treatment of this condition.
IPN, New Delhi can facilitate patient to import of "Oncology Products" for personal use under "patient name basis" treatment in India.
The list includes FDA approved brand drugs names are in some way related to, or used in the treatment of this condition.
IPN, New Delhi can facilitate patient to import of "Oncology Products" for personal use under "patient name basis" treatment in India.